Showing results (11-20 of 886) with videos related to
Sort By:
Pageof 89
Journal of Steroid Biochemistry|January 1, 1988
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choiceF Labrie, A Dupont, L Cusan, et al.Urology|March 1, 1992
Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamideS Pinault, B Têtu, J Gagnon, et al.Journal of Steroid Biochemistry|May 1, 1989
Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in menB Bélanger, A Bélanger, F Labrie, et al.Annales D'Urologie|January 1, 1986
[Combined anti-androgen treatment in adenocarcinoma of the prostate: first use of a new therapeutically efficacious principle in hormone-dependent cancer]F Labrie, A Dupont, A Bélanger, et al.The American Journal of Surgical Pathology|February 1, 1991
Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical studyB Têtu, J R Srigley, J C Boivin, et al.British Journal of Urology|November 1, 1993
Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinomaA Dupont, L Cusan, J L Gomez, et al.The Journal of Urology|March 1, 1992
Serum prostate specific antigen as pre-screening test for prostate cancerF Labrie, A Dupont, R Suburu, et al.The Journal of Clinical Endocrinology and Metabolism|September 1, 1984
Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancerA Bélanger, A Dupont, F LabrieBritish Journal of Urology|June 1, 1989
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapyF Labrie, A Dupont, A Bélanger, et al.The Prostate|January 1, 1983
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgensF Labrie, A Dupont, A Belanger, et al.Pageof 89